3Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro re- lease of dexamethasone from PLGA microspheres [ J ]. J Control Release ,2008,127 (2) : 137.
4Makino K, Nakajima T, Shikamura M. et al. Efficient in- tracellular delivery of rifampicin to alveolar maerophages using rifampiein-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampiein [ J ]. Colloids Surf B Biointerfaees, 2004,36 (1) :35.
5Du L, Cheng J, Chi Q. et al. Biodegradable PLGA micro- spheres as a sustained release system for a new luteinizing hormone-releasing hormone ( LHRH ) antagonist [J]. Chem Pharm Bu11,2006,54(9) :1259.
6Xuan J, Lin Y, Huang J, et al. Exenatide-loaded PLGA mi- crospheres with improved glycemic control :In vitro bioactivi-ty and in vivo pharmacokinetic pro? les after subcutaneous administration to SD rats [ J ]. Peptides ,2013 ,46 :172.
7Diab R, Brillault J, Bardy A, et al. Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rif- ampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer:efficiency for ex vivo alveolar mac- rophage targeting [ J]. Int J Pharm,2012,436(1-2) :833.
8Ravi S, Peh KK, Darwis Y, et al. Development and char- acterization of polymeric microspheres for controlled re- lease protein loaded drug delivery system [ J ]. Indian J Pharm Sei,2008,70 ( 3 ) :303.
